213 related articles for article (PubMed ID: 23416984)
21. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.
Dong L; Gao M; Hao WJ; Zheng XQ; Li YG; Li XL; Yu Y
Medicine (Baltimore); 2016 May; 95(22):e3695. PubMed ID: 27258496
[TBL] [Abstract][Full Text] [Related]
22. Birt-Hogg-Dubé (BHD) syndrome: report of two novel germline mutations in the folliculin (FLCN) gene.
Palmirotta R; Donati P; Savonarola A; Cota C; Ferroni P; Guadagni F
Eur J Dermatol; 2008; 18(4):382-6. PubMed ID: 18573707
[TBL] [Abstract][Full Text] [Related]
23. Early onset renal cell carcinoma in an adolescent girl with germline FLCN exon 5 deletion.
Schneider M; Dinkelborg K; Xiao X; Chan-Smutko G; Hruska K; Huang D; Sagar P; Harisinghani M; Iliopoulos O
Fam Cancer; 2018 Jan; 17(1):135-139. PubMed ID: 28623476
[TBL] [Abstract][Full Text] [Related]
24. Familial multiple discoid fibromas: a look-alike of Birt-Hogg-Dubé syndrome not linked to the FLCN locus.
Starink TM; Houweling AC; van Doorn MB; Leter EM; Jaspars EH; van Moorselaar RJ; Postmus PE; Johannesma PC; van Waesberghe JH; Ploeger MH; Kramer MT; Gille JJ; Waisfisz Q; Menko FH
J Am Acad Dermatol; 2012 Feb; 66(2):259.e1-9. PubMed ID: 21794948
[TBL] [Abstract][Full Text] [Related]
25. Absence of the Birt-Hogg-Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility.
Preston RS; Philp A; Claessens T; Gijezen L; Dydensborg AB; Dunlop EA; Harper KT; Brinkhuizen T; Menko FH; Davies DM; Land SC; Pause A; Baar K; van Steensel MA; Tee AR
Oncogene; 2011 Mar; 30(10):1159-73. PubMed ID: 21057536
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.
da Silva NF; Gentle D; Hesson LB; Morton DG; Latif F; Maher ER
J Med Genet; 2003 Nov; 40(11):820-4. PubMed ID: 14627671
[TBL] [Abstract][Full Text] [Related]
27. Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.
Schmidt LS
Fam Cancer; 2013 Sep; 12(3):357-64. PubMed ID: 23108783
[TBL] [Abstract][Full Text] [Related]
28. A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic.
Enomoto Y; Namba Y; Hoshika Y; Komemushi Y; Mitani K; Kume H; Kobayashi E; Miyama Y; Homma Y; Ushiku T; Seyama K
Eur J Med Genet; 2020 Apr; 63(4):103820. PubMed ID: 31778855
[TBL] [Abstract][Full Text] [Related]
29. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
[TBL] [Abstract][Full Text] [Related]
30. FLCN gene-mutated renal cell neoplasms: mother and daughter cases with a novel germline mutation.
Nagashima Y; Furuya M; Gotohda H; Takagi S; Hes O; Michal M; Grossmann P; Tanaka R; Nakatani Y; Kuroda N
Int J Urol; 2012 May; 19(5):468-70. PubMed ID: 22211584
[TBL] [Abstract][Full Text] [Related]
31. Loss of the Birt-Hogg-Dubé gene product folliculin induces longevity in a hypoxia-inducible factor-dependent manner.
Gharbi H; Fabretti F; Bharill P; Rinschen MM; Brinkkötter S; Frommolt P; Burst V; Schermer B; Benzing T; Müller RU
Aging Cell; 2013 Aug; 12(4):593-603. PubMed ID: 23566034
[TBL] [Abstract][Full Text] [Related]
32. Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression.
Wu M; Si S; Li Y; Schoen S; Xiao GQ; Li X; Teh BT; Wu G; Chen J
Oncotarget; 2015 Oct; 6(32):32761-73. PubMed ID: 26418749
[TBL] [Abstract][Full Text] [Related]
33. Birt-Hogg-Dubé: tumour suppressor function and signalling dynamics central to folliculin.
Tee AR; Pause A
Fam Cancer; 2013 Sep; 12(3):367-72. PubMed ID: 23096221
[TBL] [Abstract][Full Text] [Related]
34. [Birt-Hogg-Dubé syndrome].
Rehfeld A; van Steensel MA; Friis-Hansen L
Ugeskr Laeger; 2010 Jul; 172(29):2085-90. PubMed ID: 20633341
[TBL] [Abstract][Full Text] [Related]
35. A Novel FLCN Variant in a Suspected Birt-Hogg-Dubè Syndrome Patient.
Bandini E; Zampiga V; Cangini I; Ravegnani M; Arcangeli V; Rossi T; Mammi I; Schiavi F; Zovato S; Falcini F; Calistri D; Danesi R
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569793
[TBL] [Abstract][Full Text] [Related]
36. A new locus-specific database (LSDB) for mutations in the folliculin (FLCN) gene.
Lim DH; Rehal PK; Nahorski MS; Macdonald F; Claessens T; Van Geel M; Gijezen L; Gille JJ; Giraud S; Richard S; van Steensel M; Menko FH; Maher ER
Hum Mutat; 2010 Jan; 31(1):E1043-51. PubMed ID: 19802896
[TBL] [Abstract][Full Text] [Related]
37. Intratumoral peripheral small papillary tufts: a diagnostic clue of renal tumors associated with Birt-Hogg-Dubé syndrome.
Kuroda N; Furuya M; Nagashima Y; Gotohda H; Moritani S; Kawakami F; Imamura Y; Bando Y; Takahashi M; Kanayama HO; Ota S; Michal M; Hes O; Nakatani Y
Ann Diagn Pathol; 2014 Jun; 18(3):171-6. PubMed ID: 24767893
[TBL] [Abstract][Full Text] [Related]
38. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.
Hasumi H; Baba M; Hasumi Y; Lang M; Huang Y; Oh HF; Matsuo M; Merino MJ; Yao M; Ito Y; Furuya M; Iribe Y; Kodama T; Southon E; Tessarollo L; Nagashima K; Haines DC; Linehan WM; Schmidt LS
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1624-31. PubMed ID: 25775561
[TBL] [Abstract][Full Text] [Related]
39. Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dubé syndrome.
Furuya M; Yao M; Tanaka R; Nagashima Y; Kuroda N; Hasumi H; Baba M; Matsushima J; Nomura F; Nakatani Y
Clin Genet; 2016 Nov; 90(5):403-412. PubMed ID: 27220747
[TBL] [Abstract][Full Text] [Related]
40. PRDM10 directs FLCN expression in a novel disorder overlapping with Birt-Hogg-Dubé syndrome and familial lipomatosis.
van de Beek I; Glykofridis IE; Oosterwijk JC; van den Akker PC; Diercks GFH; Bolling MC; Waisfisz Q; Mensenkamp AR; Balk JA; Zwart R; Postma AV; Meijers-Heijboer HEJ; van Moorselaar RJA; Wolthuis RMF; Houweling AC
Hum Mol Genet; 2023 Mar; 32(7):1223-1235. PubMed ID: 36440963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
